{"id":"https://openalex.org/W2808422251","doi":null,"title":"Efficiency of Orientin Inhibits HMGB1: Potential Adjunct Therapeutic Agent for Septicemic Melioidosis in a Mouse Model","display_name":"Efficiency of Orientin Inhibits HMGB1: Potential Adjunct Therapeutic Agent for Septicemic Melioidosis in a Mouse Model","publication_year":2018,"publication_date":"2018-03-31","ids":{"openalex":"https://openalex.org/W2808422251","mag":"2808422251"},"language":"th","primary_location":{"id":"mag:2808422251","doi":null,"is_oa":false,"landing_page_url":"https://thaidj.org/index.php/SMNJ/article/download/2601/2339","pdf_url":null,"source":{"id":"https://openalex.org/S4306530812","display_name":"Srinagarind Medical Journal-\u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Srinagarind Medical Journal-\u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044498546","display_name":"Ratthiya Thiabma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ratthiya Thiabma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063928430","display_name":"Arunee Paeyao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arunee Paeyao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082192904","display_name":"Surasakdi Wongratanacheewin","orcid":"https://orcid.org/0000-0003-2921-2536","observed_orcids":["https://orcid.org/0000-0003-2921-2536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Surasakdi Wongratanacheewin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2921-2536","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"1","first_page":"32","last_page":"37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12951","display_name":"Burkholderia infections and melioidosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12951","display_name":"Burkholderia infections and melioidosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orientin","display_name":"orientin","score":0.9549999833106995},{"id":"https://openalex.org/keywords/hmgb1","display_name":"HMGB1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/septicemic-melioidosis","display_name":"septicemic melioidosis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/burkholderia-pseudomallei","display_name":"Burkholderia pseudomallei","score":0.996999979019165},{"id":"https://openalex.org/keywords/ceftazidime","display_name":"ceftazidime","score":0.8880000114440918},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.7110000252723694},{"id":"https://openalex.org/keywords/survival-rate","display_name":"survival rate","score":0.6430000066757202},{"id":"https://openalex.org/keywords/sepsis-treatment","display_name":"sepsis treatment","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C2777655684","wikidata":"https://www.wikidata.org/wiki/Q421676","display_name":"Orientin","level":5,"score":0.759367823600769},{"id":"https://openalex.org/C2780545709","wikidata":"https://www.wikidata.org/wiki/Q21130552","display_name":"HMGB1","level":3,"score":0.6038633584976196},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4534974992275238},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.453456848859787},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.44635942578315735},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.43763548135757446},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.418935090303421},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3892993628978729},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38281044363975525},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.32218724489212036},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3150157034397125},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.200787752866745},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08378088474273682},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.0},{"id":"https://openalex.org/C2779054382","wikidata":"https://www.wikidata.org/wiki/Q72185287","display_name":"Flavonoid","level":3,"score":0.0},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.0},{"id":"https://openalex.org/C2779301978","wikidata":"https://www.wikidata.org/wiki/Q259075","display_name":"Vitexin","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2808422251","doi":null,"is_oa":false,"landing_page_url":"https://thaidj.org/index.php/SMNJ/article/download/2601/2339","pdf_url":null,"source":{"id":"https://openalex.org/S4306530812","display_name":"Srinagarind Medical Journal-\u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Srinagarind Medical Journal-\u0e28\u0e23\u0e35\u0e19\u0e04\u0e23\u0e34\u0e19\u0e17\u0e23\u0e4c\u0e40\u0e27\u0e0a\u0e2a\u0e32\u0e23","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1600734270","https://openalex.org/W1970456030","https://openalex.org/W1972442585","https://openalex.org/W1983348216","https://openalex.org/W1999559353","https://openalex.org/W2013907687","https://openalex.org/W2092550804","https://openalex.org/W2114445825","https://openalex.org/W2121050313","https://openalex.org/W2149156757","https://openalex.org/W2160369507","https://openalex.org/W2164714222"],"related_works":["https://openalex.org/W2013907687","https://openalex.org/W2938708446","https://openalex.org/W1950166802","https://openalex.org/W2166060104","https://openalex.org/W2998364743","https://openalex.org/W2066036155","https://openalex.org/W2145265094","https://openalex.org/W7096074189","https://openalex.org/W2093336969","https://openalex.org/W2338792889"],"abstract_inverted_index":{"Background":[0],"and":[1,112,114,133,145,170,184,234],"Objective:":[2],"\u00a0HMGB1":[5],"is":[6],"a":[7,238],"potent":[8],"proinflammatorycytokine":[9],"in":[10,48,131,136,168,176,181,192,217,232,237],"septicemic":[11],"melioidosis":[12],"patients.":[13],"The":[14,27,71,161,173],"HMGB1":[15,134,187,235,253,331,334,339,397,429,448],"level":[16,135,191,236],"was":[17,32,166,178],"found":[18,167,179],"to":[19,33,69,125,205,227],"be":[20],"correlated":[21],"with":[22,66,77,102,109,159,219],"severity":[23],"of":[24,29,37,40,61,120,129,208,215,223,230,241],"the":[25,35,38,106,127,149,189,213],"disease.":[26],"aim":[28],"this":[30],"study":[31],"investigate":[34],"effective":[36],"potential":[39,214],"HMGB1-inhibitor,":[41],"orientin,":[42],"as":[43,202],"an":[44,203],"adjunct":[45],"therapeutic":[46],"agent":[47],"septicemicmelioidosis":[49],"mice.":[50],"Methods:":[54],"Four":[59],"groups":[60,147],"BALB/c":[62,351],"mice":[63,73,122,218],"were":[64,74,123],"infected":[65,72,121],"Burkholderiapseudomallei":[68,360],"inducesepticemicmelioidosis.":[70],"then":[75],"treated":[76],"various":[78],"substances":[79],"including":[80],"group":[81,87,98,110,158,183],"I)":[82,111],"\u00a0Phosphate":[83,367],"Bufferred":[84],"Saline":[85,369],"(PBS),":[86],"II)":[88,113],"Ceftazidime":[89,103],"(CTZ),":[90],"300":[91],"mg/kg,group":[92],"III)":[93],"Orientin":[94,100],"(Ori)":[95],"36":[96],"\u00b5g/mouseand":[97],"IV)":[99],"combines":[101],"(Ori/CTZ)":[104,389],"at":[105,153],"same":[107],"concentrations":[108],"observed":[115],"their":[116],"survival.":[117],"Blood":[118],"samples":[119],"collected":[124],"determine":[126],"number":[128,229],"bacteria":[130,174,231],"blood":[132,177,233],"plasma.":[137],"Results:":[141],"CTZ":[144,209,388,409,422,443],"Ori/CTZ-treated":[146,171],"gave":[148],"highest":[150,162,190],"survival":[151,164],"rate":[152],"33.3%,":[154],"followed":[155],"by":[156],"Ori-treated":[157,182,193],"11.1%.":[160],"median":[163],"time":[165],"CTZ-":[169],"groups.":[172],"count":[175],"only":[180],"PBS-control":[185],"group.":[186,194],"showed":[188],"Conclusion:":[198],"Ori":[201,386,416,425,431],"adjunctive":[204],"suboptimal":[206],"dose":[207,379],"could":[210],"not":[211],"improve":[212],"treatment":[216],"septicemicmelioidosis.":[220],"Moreover,":[221],"administration":[222],"orientin":[224],"alone":[225],"trended":[226],"increase":[228],"mouse":[239],"model":[240],"melioidosis.":[242],"\u0e1b\u0e23\u0e30\u0e2a\u0e17\u0e18\u0e20\u0e32\u0e1e\u0e02\u0e2d\u0e07\u0e2d\u0e2d\u0e40\u0e23\u0e22\u0e19\u0e15\u0e19\u0e15\u0e2d\u0e01\u0e32\u0e23\u0e22\u0e1a\u0e22\u0e07\u0e42\u0e1b\u0e23\u0e15\u0e19":[248],"\u0e40\u0e21\u0e2d\u0e43\u0e0a\u0e43\u0e19\u0e01\u0e32\u0e23\u0e23\u0e27\u0e21\u0e23\u0e01\u0e29\u0e32\u0e42\u0e23\u0e04\u0e15\u0e14\u0e40\u0e0a\u0e2d\u0e40\u0e21\u0e25\u0e2d\u0e2d\u0e22\u0e14\u0e41\u0e1a\u0e1a\u0e15\u0e14\u0e40\u0e0a\u0e2d\u0e43\u0e19\u0e01\u0e23\u0e30\u0e41\u0e2a\u0e40\u0e25\u0e2d\u0e14\u0e43\u0e19\u0e2b\u0e19\u0e17\u0e14\u0e25\u0e2d\u0e07":[255],"\u0e23\u0e0a\u0e17\u0e22\u0e32":[261],"\u0e40\u0e17\u0e22\u0e1a\u0e21\u0e32":[262],"1":[265,288,366],",":[268,276],"\u0e2d\u0e23\u0e13":[269],"\u0e41\u0e1b\u0e22\u0e32\u0e27":[270],"2":[273,302,372,391],"\u0e2a\u0e23\u0e28\u0e01\u0e14":[278],"\u0e27\u0e07\u0e28\u0e23\u0e15\u0e19\u0e0a\u0e27\u0e19":[279],"1,2*":[281],"\u0e20\u0e32\u0e04\u0e27\u0e0a\u0e32\u0e08\u0e25\u0e0a\u0e27\u0e27\u0e17\u0e22\u0e32":[293],"\u0e04\u0e13\u0e30\u0e41\u0e1e\u0e17\u0e22\u0e28\u0e32\u0e2a\u0e15\u0e23":[294,308],"\u0e21\u0e2b\u0e32\u0e27\u0e17\u0e22\u0e32\u0e25\u0e22\u0e02\u0e2d\u0e19\u0e41\u0e01\u0e19":[295,309],"\u0e28\u0e19\u0e22\u0e27\u0e08\u0e22\u0e42\u0e23\u0e04\u0e40\u0e21\u0e25\u0e2d\u0e2d\u0e22\u0e42\u0e14\u0e2a\u0e2a":[307],"*":[316],"\u0e1c\u0e23\u0e1a\u0e1c\u0e14\u0e0a\u0e2d\u0e1a\u0e27\u0e17\u0e22\u0e32\u0e19\u0e1e\u0e19\u0e18\u0e15\u0e19\u0e09\u0e1a\u0e1a":[318],"\u0e2b\u0e25\u0e01\u0e01\u0e32\u0e23\u0e41\u0e25\u0e30\u0e27\u0e15\u0e16\u0e1b\u0e23\u0e30\u0e2a\u0e07\u0e04":[324],":":[328,348,406,439],"\u0e42\u0e1b\u0e23\u0e15\u0e19":[330],"\u0e40\u0e1b\u0e19\u0e15\u0e27\u0e01\u0e23\u0e30\u0e15\u0e19\u0e01\u0e32\u0e23\u0e2d\u0e01\u0e40\u0e2a\u0e1a\u0e17\u0e21\u0e1a\u0e17\u0e1a\u0e32\u0e17\u0e2a\u0e33\u0e04\u0e0d\u0e43\u0e19\u0e1c\u0e1b\u0e27\u0e22\u0e17\u0e15\u0e14\u0e40\u0e0a\u0e2d\u0e40\u0e21\u0e25\u0e2d\u0e2d\u0e22\u0e14\u0e43\u0e19\u0e01\u0e23\u0e30\u0e41\u0e2a\u0e40\u0e25\u0e2d\u0e14":[332],"\u0e23\u0e30\u0e14\u0e1a\u0e02\u0e2d\u0e07":[333],"\u0e16\u0e01\u0e1e\u0e1a\u0e27\u0e32\u0e2a\u0e21\u0e1e\u0e19\u0e18\u0e01\u0e1a\u0e04\u0e27\u0e32\u0e21\u0e23\u0e19\u0e41\u0e23\u0e07\u0e02\u0e2d\u0e07\u0e42\u0e23\u0e04":[335],"\u0e01\u0e32\u0e23\u0e28\u0e01\u0e29\u0e32\u0e19\u0e21\u0e27\u0e15\u0e16\u0e1b\u0e23\u0e30\u0e2a\u0e07\u0e04\u0e40\u0e1e\u0e2d\u0e2a\u0e1a\u0e2a\u0e27\u0e19\u0e1b\u0e23\u0e30\u0e2a\u0e17\u0e18\u0e20\u0e32\u0e1e\u0e02\u0e2d\u0e07\u0e2a\u0e32\u0e23\u0e2d\u0e2d\u0e40\u0e23\u0e22\u0e19\u0e15\u0e19":[336],"(orientin)":[337],"\u0e17\u0e2a\u0e32\u0e21\u0e32\u0e23\u0e16\u0e22\u0e1a\u0e22\u0e07":[338],"\u0e43\u0e19\u0e01\u0e32\u0e23\u0e23\u0e27\u0e21\u0e23\u0e01\u0e29\u0e32\u0e2b\u0e19\u0e17\u0e15\u0e14\u0e40\u0e0a\u0e2d\u0e40\u0e21\u0e25\u0e2d\u0e2d\u0e22\u0e14\u0e43\u0e19\u0e01\u0e23\u0e30\u0e41\u0e2a\u0e40\u0e25\u0e2d\u0e14":[340],"\u0e27\u0e18\u0e01\u0e32\u0e23\u0e28\u0e01\u0e29\u0e32":[344],"\u0e2b\u0e19":[350],"\u0e08\u0e33\u0e19\u0e27\u0e19":[352],"4":[353],"\u0e01\u0e25\u0e21":[354],"(\u0e01\u0e25\u0e21\u0e25\u0e30":[355],"6":[356],"\u0e15\u0e27)":[357],"\u0e16\u0e01\u0e17\u0e33\u0e43\u0e2b\u0e15\u0e14\u0e40\u0e0a\u0e2d\u00a0":[358],"\u0e40\u0e1e\u0e2d\u0e0a\u0e01\u0e19\u0e33\u0e43\u0e2b\u0e40\u0e01\u0e14\u0e20\u0e32\u0e27\u0e30\u0e15\u0e14\u0e40\u0e0a\u0e2d\u0e43\u0e19\u0e01\u0e23\u0e30\u0e41\u0e2a\u0e40\u0e25\u0e2d\u0e14":[361],"\u0e41\u0e25\u0e30\u0e43\u0e2b\u0e01\u0e32\u0e23\u0e23\u0e01\u0e29\u0e32\u0e14\u0e27\u0e22\u0e2a\u0e32\u0e23\u0e15\u0e32\u0e07":[362],"\u0e46":[363],"\u0e14\u0e07\u0e19":[364],"\u0e01\u0e25\u0e21\u0e17":[365,371,376],"Buffered":[368],"(PBS)":[370],"\u0e2d\u0e2d\u0e40\u0e23\u0e22\u0e19\u0e15\u0e19(Ori)":[373],"\u0e04\u0e27\u0e32\u0e21\u0e40\u0e02\u0e21\u0e02\u0e1936":[374],"\u0e44\u0e21\u0e42\u0e04\u0e23\u0e01\u0e23\u0e21\u0e15\u0e2d\u0e15\u0e27":[375],"3":[377,393],"\u00a0\u0e40\u0e0b\u0e1f\u0e15\u0e32\u0e0b\u0e14\u0e21\u0e17\u0e21":[378],"\u0e15\u0e33":[380],"(CTZ)":[381],"\u0e04\u0e27\u0e32\u0e21\u0e40\u0e02\u0e21\u0e02\u0e19300":[382],"\u0e21\u0e25\u0e25\u0e01\u0e23\u0e21\u0e15\u0e2d\u0e01\u0e42\u0e25\u0e01\u0e23\u0e21":[383],"\u0e41\u0e25\u0e30\u0e01\u0e25\u0e21\u0e17":[384],"4\u00a0":[385],"\u0e23\u0e27\u0e21\u0e01\u0e1a":[387],"\u0e17\u0e04\u0e27\u0e32\u0e21\u0e40\u0e02\u0e21\u0e40\u0e02\u0e19\u0e40\u0e14\u0e22\u0e27\u0e01\u0e19\u0e01\u0e1a\u0e01\u0e25\u0e21":[390],"\u0e41\u0e25\u0e30":[392,410,423],"\u0e08\u0e32\u0e01\u0e19\u0e19":[394],"\u0e2a\u0e07\u0e40\u0e01\u0e15\u0e04\u0e27\u0e32\u0e21\u0e21\u0e0a\u0e27\u0e15\u0e23\u0e2d\u0e14":[395],"\u0e41\u0e25\u0e30\u0e40\u0e01\u0e1a\u0e15\u0e27\u0e2d\u0e22\u0e32\u0e07\u0e40\u0e25\u0e2d\u0e14\u0e40\u0e1e\u0e2d\u0e15\u0e23\u0e27\u0e08\u0e14\u0e08\u0e33\u0e19\u0e27\u0e19\u0e41\u0e1a\u0e04\u0e17\u0e40\u0e23\u0e22\u0e43\u0e19\u0e40\u0e25\u0e2d\u0e14\u0e41\u0e25\u0e30\u0e1b\u0e23\u0e21\u0e32\u0e13\u0e02\u0e2d\u0e07":[396],"\u0e43\u0e19\u0e1e\u0e25\u0e32\u0e2a\u0e21\u0e32":[398],"\u0e1c\u0e25\u0e01\u0e32\u0e23\u0e28\u0e01\u0e29\u0e32":[402],"\u0e01\u0e25\u0e21\u0e17\u0e43\u0e2b\u0e01\u0e32\u0e23\u0e23\u0e01\u0e29\u0e32\u0e14\u0e27\u0e22":[408,421],"Ori/CTZ":[411],"\u0e21\u0e2d\u0e15\u0e23\u0e32\u0e01\u0e32\u0e23\u0e21\u0e0a\u0e27\u0e15\u0e23\u0e2d\u0e14\u0e2a\u0e07\u0e2a\u0e14":[412],"\u0e23\u0e2d\u0e22\u0e25\u0e30":[413,417],"33.3":[414],"\u0e23\u0e2d\u0e07\u0e25\u0e07\u0e21\u0e32\u0e04\u0e2d\u0e01\u0e25\u0e21":[415],"11.1":[418],"\u0e04\u0e32\u0e01\u0e25\u0e32\u0e07\u0e40\u0e27\u0e25\u0e32\u0e21\u0e0a\u0e27\u0e15\u0e23\u0e2d\u0e14\u0e2a\u0e07\u0e2a\u0e14":[419],"\u0e04\u0e2d":[420],"Ori/CTZ\u0e41\u0e1a\u0e04\u0e17\u0e40\u0e23\u0e22\u0e43\u0e19\u0e40\u0e25\u0e2d\u0e14\u0e16\u0e01\u0e15\u0e23\u0e27\u0e08\u0e1e\u0e1a\u0e40\u0e1e\u0e22\u0e07\u0e43\u0e19\u0e01\u0e25\u0e21\u0e17\u0e43\u0e2b\u0e01\u0e32\u0e23\u0e23\u0e01\u0e29\u0e32\u0e14\u0e27\u0e22":[424],"\u0e41\u0e25\u0e30\u0e01\u0e25\u0e21\u0e04\u0e27\u0e1a\u0e04\u0e21":[426],"PBS":[427],"\u0e2a\u0e27\u0e19\u0e23\u0e30\u0e14\u0e1a":[428],"\u0e1e\u0e1a\u0e2a\u0e07\u0e2a\u0e14\u0e43\u0e19\u0e01\u0e25\u0e21":[430],"\u0e2a\u0e23\u0e1b":[435],"\u0e01\u0e32\u0e23\u0e23\u0e01\u0e29\u0e32\u0e14\u0e27\u0e22":[441],"Ori\u0e23\u0e27\u0e21\u0e01\u0e1a":[442],"\u0e44\u0e21\u0e2a\u0e32\u0e21\u0e32\u0e23\u0e16\u0e40\u0e1e\u0e21\u0e1b\u0e23\u0e30\u0e2a\u0e17\u0e18\u0e20\u0e32\u0e1e\u0e43\u0e19\u0e01\u0e32\u0e23\u0e23\u0e01\u0e29\u0e32\u0e2b\u0e19\u0e17\u0e15\u0e14\u0e40\u0e0a\u0e2d\u0e40\u0e21\u0e25\u0e2d\u0e2d\u0e22\u0e14\u0e43\u0e19\u0e01\u0e23\u0e30\u0e41\u0e2a\u0e40\u0e25\u0e2d\u0e14":[444],"\u0e21\u0e32\u0e01\u0e44\u0e1b\u0e01\u0e27\u0e32\u0e19\u0e19":[445],"\u0e01\u0e32\u0e23\u0e43\u0e2bOri":[446],"\u0e2d\u0e22\u0e32\u0e07\u0e40\u0e14\u0e22\u0e27\u0e17\u0e33\u0e43\u0e2b\u0e08\u0e33\u0e19\u0e27\u0e19\u0e41\u0e1a\u0e04\u0e17\u0e40\u0e23\u0e22\u0e43\u0e19\u0e40\u0e25\u0e2d\u0e14\u0e41\u0e25\u0e30\u0e23\u0e30\u0e14\u0e1a":[447],"\u0e43\u0e19\u0e1e\u0e25\u0e32\u0e2a\u0e21\u0e32\u0e40\u0e1e\u0e21\u0e02\u0e19":[449]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2018-06-21T00:00:00"}